 Bindu Hegde, PhD
|
| Title(s) | Postdoctoral Scholar, Neurological Surgery |
|---|
| School | School of Medicine |
|---|
| Address | 1450 Third St
San Francisco CA 94158
|
|---|
| Phone | 415-476-1637 |
|---|
| Email | bindu.hegde@ucsf.edu |
|---|
| vCard | Download vCard |
|---|
|
|
 Biography | University of Louisville, Louisville | PhD | 03/2018 | Immunology |
ORNG Applications Bibliographic
Altmetrics Details
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media.
(Note that publications are often cited in additional ways that are not shown here.)
Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication.
Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.)
Click a Field or Translation tag to filter the publications.
-
Considerations when treating high-grade pediatric glioma patients with immunotherapy. Expert Rev Neurother. 2021 Feb; 21(2):205-219.
Crotty E, Downey K, Ferrerosa L, Flores C, Hegde B, Raskin S, Hwang E, Vitanza N, Okada H. PMID: 33225764.
View in: PubMed Mentions: Fields:
-
Zinc Oxide Nanowires Exposure Induces a Distinct Inflammatory Response via CCL11-Mediated Eosinophil Recruitment. Front Immunol. 2019; 10:2604.
Alghsham RS, Satpathy SR, Bodduluri SR, Hegde B, Jala VR, Twal W, Burlison JA, Sunkara M, Haribabu B. PMID: 31787980.
View in: PubMed Mentions: 2 Fields: Translation: AnimalsCells
-
Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy. Front Immunol. 2018; 9:3062.
Chuntova P, Downey KM, Hegde B, Almeida ND, Okada H. PMID: 30740109.
View in: PubMed Mentions: 7 Fields: Translation: HumansCells
-
Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway. Nat Commun. 2019 01 09; 10(1):89.
Singh R, Chandrashekharappa S, Bodduluri SR, Baby BV, Hegde B, Kotla NG, Hiwale AA, Saiyed T, Patel P, Vijay-Kumar M, Langille MGI, Douglas GM, Cheng X, Rouchka EC, Waigel SJ, Dryden GW, Alatassi H, Zhang HG, Haribabu B, Vemula PK, Jala VR. PMID: 30626868.
View in: PubMed Mentions: 34 Fields: Translation: HumansAnimalsCells
-
Inflammasome-Independent Leukotriene B4 Production Drives Crystalline Silica-Induced Sterile Inflammation. J Immunol. 2018 05 15; 200(10):3556-3567.
Hegde B, Bodduluri SR, Satpathy SR, Alghsham RS, Jala VR, Uriarte SM, Chung DH, Lawrenz MB, Haribabu B. PMID: 29610142.
View in: PubMed Mentions: 6 Fields: Translation: HumansAnimalsCells
-
A semi-synthetic natural product blocks collagen induced arthritis by preferentially suppressing the production of IL-6. Int Immunopharmacol. 2016 Apr; 33:63-9.
Kulkarni-Almeida A, Shah M, Jadhav M, Hegde B, Trivedi J, Mishra PD, Mahajan GB, Dadarkar S, Gupte R, Dagia N. PMID: 26869203.
View in: PubMed Mentions: 1 Fields: Translation: HumansAnimalsCells
-
Crystalline silica-induced leukotriene B4-dependent inflammation promotes lung tumour growth. Nat Commun. 2015 Apr 29; 6:7064.
Satpathy SR, Jala VR, Bodduluri SR, Krishnan E, Hegde B, Hoyle GW, Fraig M, Luster AD, Haribabu B. PMID: 25923988.
View in: PubMed Mentions: 26 Fields: Translation: AnimalsCells
-
NF-κB dependent anti-inflammatory activity of chlorojanerin isolated from Saussurea heteromalla. Phytomedicine. 2012 Aug 15; 19(11):988-97.
Saklani A, Hegde B, Mishra P, Singh R, Mendon M, Chakrabarty D, Kamath DV, Lobo A, Mishra PD, Dagia NM, Padigaru M, Kulkarni-Almeida AA. PMID: 22762939.
View in: PubMed Mentions: 1 Fields: Translation: HumansAnimalsCells
-
Vitamin E is a MIF Inhibitor. Biochem Biophys Res Commun. 2012 Feb 10; 418(2):384-9.
Hegde B, Vadnal P, Sanghavi J, Korde V, Kulkarni-Almeida AA, Dagia NM. PMID: 22281490.
View in: PubMed Mentions: 1 Fields: Translation: HumansCells
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
| Year | Publications |
|---|
| 2012 | 2 | | 2015 | 1 | | 2016 | 1 | | 2018 | 1 | | 2019 | 3 | | 2020 | 1 |
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
This graph shows the number and percent of publications by field.
Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications.
Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written.
To see the data as text, click here.
newest
oldest
line numbers
double spacing
all authors
publication IDs
|
Derived automatically from this person's publications.
_
People in Profiles who have published with this person.
_
People who share similar concepts with this person.
_
Search Department
_
|